Even before artificial intelligence raised many young adults' concerns about future work opportunities, the struggle to live independently was real. A recent study from Northwestern Mutual found that 42% of Americans over 18 still rely on their parents for financial support.
Inflation, housing cost.... |
Good MorningU.S. stocks finished mixed Tuesday, with the Dow eking out a gain while the S&P 500 and Nasdaq closed lower as technology stocks sold off. The major ETFs SPY and QQQ recovered some intraday losses, but investors remained cautious amid headlines about potential Iran war escalation and broader risk-off pressure in growth stocks.
AI and cloud remained central market themes. Oracle earnings are due after market close on June 10, with investors watching whether AI-driven cloud demand is translating into faster growth, especially given its large OpenAI data center relationship.
Corporate news was active across sectors. Flex will join the S&P 500 on June 22, Hubbell completed its $3 billion acquisition of NSI Industries, and a judge gave preliminary approval to a Visa and Mastercard swipe-fee settlement. CME Group launched Nasdaq CME Crypto Index futures, while Visa is testing stablecoin settlement and AI payment tools. In earnings and guidance, Cracker Barrel raised its fiscal outlook, Suja Life reported 22.5% sales growth, and BARK reported a 25% revenue decline. Featured: The quietest monopoly in energy (Ad) 
| Finance | |
Even before artificial intelligence raised many young adults' concerns about future work opportunities, the struggle to live independently was real. A recent study from Northwestern Mutual found that 42% of Americans over 18 still rely on their parents for financial support.
Inflation, housing cost... Read the Full Story |
| From Our Partners | | Bill Gates wrote a $100 million check. Google signed a 15-year contract. The Pentagon named it their top energy priority. All three are backing the same company - and the same energy source that holds 140 times global electricity demand.
Last year a drilling crew cracked through three miles of solid rock in 16 days - the government had projected 64. On August 18th, Washington is handing this technology a tax credit advantage that solar and wind no longer receive. | | See the company Gates, Google, and the Pentagon are all backing |
| Technology | |
The recent multibillion-dollar infrastructure pact between Amazon (NASDAQ: AMZN) and Corning (NYSE: GLW) cements a structural shift in hardware for artificial intelligence. The physical transmission limits of copper have been breached, mandating dense optical fiber for next-generation compute clus... Read the Full Story |
| Retail/Wholesale | |
Amazon.com Inc (NASDAQ: AMZN) has had a difficult few weeks. The stock is trading right around $240, having been as high as $278 just a month ago, and is back to the level it traded at last October.
While the S&P 500 has quietly added around 2% over the same couple of weeks, Amazon has given b... Read the Full Story |
| From Our Partners | | Frontieras is using patented FASForm technology to convert coal into hydrogen, diesel, jet fuel, and fertilizer - without burning it - targeting $2.1 trillion in combined markets.
With a $150M investment commitment from GEM, over $30M raised from private investors, a NASDAQ ticker reserved, and an $850M flagship facility breaking ground in West Virginia, 2026 is shaping up as a pivotal year. The share price is set to increase after August 6. | | Join over 12,000 shareholders and invest at $9.01 per share today |
| Technology | |
Cryptocurrency markets began soaring following the 2024 U.S. presidential election, reaching new all-time highs in August 2025 as the crypto-friendly Trump administration began implementing policies. But this summer has been anything but sunny for crypto markets. Bitcoin has erased all its post-ele... Read the Full Story |
| Consumer Staples | |
The J.M. Smucker Company (NYSE: SJM) may not pay the highest-yielding dividend among S&P 500 companies, but it still offers a sweet payout and is on track for annual increases alongside share price appreciation. The net result will be a double-digit compound annual growth rate (CAGR) over the ... Read the Full Story |
| From Our Partners | | Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film.
Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business. | | Watch the full investigation and decide for yourself |
| Finance | |
Insiders are making big moves in several key stocks across finance and tech. This includes rare buys at a crypto-linked name that is well-known among retail investors. Meanwhile, insiders are selling a stock that received swaths of analyst upgrades last month, and a surging chip company with ties t... Read the Full Story |
| Technology | |
The big players have shown up to the quantum computing race, and the results could be disastrous for smaller names. IBM Corp. (NYSE: IBM) notched two big wins in recent weeks, securing $1 billion in foundry funding from the federal government and leaning into quantum R&D with $10 billion in pla... Read the Full Story |
| Technology | |
Apple Inc. (NASDAQ: AAPL) started the week with an almost-perfect setup. Multiple quarters of solid results, a market that’s been steadily repricing the stock higher on AI optimism, and bullish expectations for what would be announced at its annual Worldwide Developers Conference (WWDC), which is r... Read the Full Story |
| Retail/Wholesale | |
Shares of Chinese e-commerce giant and Temu-owner PPD (NASDAQ: PDD) came under significant pressure at the end of 2025 and early 2026. In Q4 2025, shares fell more than 14%, and Q1 2026 saw a nearly 10% drop.
Rather than staging a rebound after these falls, pressure has continued to mount. In Q2 2... Read the Full Story |
| Transportation | |
Tanker and shipping stocks might not be the first thing that comes to investors' minds when they think of “high yield." However, shipping companies can sometimes deliver very significant dividends when times are good. Times are, in fact, good for several names in this space, leading to significant ... Read the Full Story |
| Wednesday's Early Bird Stock Of The Day Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana. | Should I Buy Eli Lilly and Company Stock? LLY Bull and Bear Case Explained
These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Eli Lilly and Company was last updated on Thursday, July 23, 2026 at 6:04 PM.
Eli Lilly and Company Bull Case -
The company has demonstrated impressive financial performance, with a return on equity exceeding 100%, indicating effective management and profitability.
-
Eli Lilly and Co recently reported earnings per share significantly above analysts' expectations, showcasing strong operational efficiency and market demand for its products.
-
The current stock price is around $720, reflecting a robust market position and investor confidence in the company's future growth prospects.
-
With a net margin of nearly 35%, Eli Lilly and Co is effectively converting a substantial portion of its revenue into profit, which is attractive for potential investors.
-
The company has a solid dividend payout ratio, allowing for consistent returns to shareholders while still reinvesting in growth opportunities.
Eli Lilly and Company Bear Case -
Despite strong earnings, the pharmaceutical industry is highly competitive, and Eli Lilly and Co faces pressure from generic alternatives and pricing regulations.
-
The company's reliance on a few key products for revenue could pose risks if market dynamics shift or if new competitors emerge.
-
While the dividend yield is currently low, it may not be sufficient to attract income-focused investors compared to other investment opportunities.
-
Institutional investors hold a significant portion of the stock, which can lead to volatility if large shareholders decide to sell their positions.
-
Future earnings guidance may be subject to change based on regulatory approvals and market conditions, introducing uncertainty for investors.
| | View Today's Stock Pick |
|
| |
|
|
